Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.
Evans, D., Woodward, E. R., Howell, S. J., Verhoef, S., Howell, A. & Lalloo, F.
Familial Cancer. 2016
Breast cancer risk feedback to women in the UK NHS breast screening population
Evans, D. G. R., Donnelly, L. S., Harkness, E. F., Astley, S. M., Stavrinos, P., Dawe, S., Watterson, D., Fox, L., Sergeant, J. C., Ingham, S., Harvie, M. N., Wilson, M., Beetles, U., Buchan, I., Brentnall, A. R., French, D. P., Cuzick, J. & Howell, A.
British Journal of Cancer. 114, 9, p. 1045-52 8 p. 2016.
Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
Evans, G., Harkness, E., Howell, A., Wilson, M., Hurley, E., Holmen, M. M., Tharmaratnam, K. U., Hagen, A. I., Lim, Y., Maxwell, A. & Moller, P.
Hereditary cancer in clinical practice. 14, 8. 2016
MRI Screening in Women With a Personal History of Breast cancer
Evans, G. & Maxwell, A.
Journal of the National Cancer Institute. 108, 3, djv373. 2016
No strong evidence for increased risk of breast cancer 8-26 years after multiple mammograms in their 30s in females at moderate and high familial risk.
Evans, D. G., Kotre, C. J., Harkness, E., Wilson, M., Maxwell, A. J. & Howell, A.
British Journal of Radiology. 89, 1059. 2016
Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens
Evans, G., Lalloo, F., Howell, S., Verhoef, S., Woodward, E. R. & Howell, A.
Breast Cancer Research and Treatment. 155, 3, p. 597-601 5 p. 2016
Is there really an increased risk of early colorectal cancer in women with BRCA1 pathogenic mutations?
Evans, G., Clancy, T., Hill, J. & Tischkowitz, M.
Clinical Genetics. 89, 3, p. 399. 2016
Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.
Basu, N. N., Littlechild, S., Barr, L., Ross, G. L. & Evans, D. G.
Annals of the Royal College of Surgeons of England. 2016
The impact of a panel of 18 single nucleotide polymorphisms on breast cancer risk in women attending a UK familial-screening clinic: A case-control study
Evans, D., Brentnall, A. R., Byers, H., Harkness, E., Stavrinos, P., Howell, A., Newman, W. & Cuzick, J.
Journal of Medical Genetics. 2016
Can the breast screening appointment be used to provide risk assessment and prevention advice?
Evans DG, Howell A.
Breast Cancer Res. 2015 Jul 9;17:84. doi: 10.1186/s13058-015-0595-y.
Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.
Harkness EF, Barrow E, Newton K, Green K, Clancy T, Lalloo F, Hill J, Evans DG.
J Med Genet. 2015 Aug;52(8):553-6. doi: 10.1136/jmedgenet-2015-103216.
Gene-panel sequencing and the prediction of breast-cancer risk.
Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD.
N Engl J Med. 2015 Jun 4;372(23):2243-57. doi: 10.1056/NEJMsr1501341.
Can diet and lifestyle prevent breast cancer: what is the evidence?
Harvie M, Howell A, Evans DG.
Am Soc Clin Oncol Educ Book. 2015;35:e66-73. doi: 10.14694/EdBook_AM.2015.35.e66.
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Blein S et al.
Breast Cancer Res. 2015 Apr 25;17:61. doi: 10.1186/s13058-015-0567-2.
Common germline polymorphisms associated with breast cancer-specific survival.
Pirie A et al.
Breast Cancer Res. 2015 Apr 22;17:58. doi: 10.1186/s13058-015-0570-7.
General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles.
Julian-Reynier C, Bouhnik AD, Evans DG, Harris H, van Asperen CJ, Tibben A, Schmidtke J, Nippert I.
BMC Cancer. 2015 Apr 9;15:243. doi: 10.1186/s12885-015-1281-2.
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Rebbeck TR et al.
JAMA. 2015 Apr 7;313(13):1347-61. doi: 10.1001/jama.2014.5985.
Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention.
Wright CE, Harvie M, Howell A, Evans DG, Hulbert-Williams N, Donnelly LS.
Hered Cancer Clin Pract. 2015 Jan 9;13(1):1. doi: 10.1186/s13053-014-0023-9.
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Peterlongo P, et al.
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):308-16. doi: 10.1158/1055-9965.EPI-14-0532.
A clinical and genetic analysis of multiple primary cancer referrals to genetics services.
Whitworth J, Hoffman J, Chapman C, Ong KR, Lalloo F, Evans DG, Maher ER.
Eur J Hum Genet. 2015 May;23(5):581-7. doi: 10.1038/ejhg.2014.157.